TriSalus Life Sciences, Inc. (TLSI)
4.985
-0.16
(-3.02%)
USD |
NASDAQ |
Sep 03, 16:00
4.985
0.00 (0.00%)
After-Hours: 19:09
TriSalus Life Sciences Market Cap : 306.43M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 02, 2026 | 315.95M |
| September 01, 2026 | 317.80M |
| August 31, 2026 | 304.27M |
| August 28, 2026 | 296.90M |
| August 27, 2026 | 303.05M |
| August 26, 2026 | 303.05M |
| August 25, 2026 | 309.19M |
| August 24, 2026 | 314.11M |
| August 21, 2026 | 323.94M |
| August 20, 2026 | 321.49M |
| August 19, 2026 | 337.47M |
| August 18, 2026 | 331.94M |
| August 17, 2026 | 323.94M |
| August 14, 2026 | 323.94M |
| August 13, 2026 | 346.07M |
| August 12, 2026 | 350.99M |
| August 11, 2026 | 352.84M |
| August 10, 2026 | 343.00M |
| August 07, 2026 | 344.84M |
| August 06, 2026 | 299.36M |
| August 05, 2026 | 283.99M |
| August 04, 2026 | 291.37M |
| August 03, 2026 | 291.72M |
| July 31, 2026 | 278.82M |
| July 30, 2026 | 280.05M |
| Date | Value |
|---|---|
| July 29, 2026 | 269.00M |
| July 28, 2026 | 265.92M |
| July 27, 2026 | 265.31M |
| July 24, 2026 | 259.17M |
| July 23, 2026 | 262.24M |
| July 22, 2026 | 260.40M |
| July 21, 2026 | 266.54M |
| July 20, 2026 | 264.70M |
| July 17, 2026 | 263.47M |
| July 16, 2026 | 267.77M |
| July 15, 2026 | 251.80M |
| July 14, 2026 | 248.11M |
| July 13, 2026 | 259.78M |
| July 10, 2026 | 254.26M |
| July 09, 2026 | 238.90M |
| July 08, 2026 | 226.00M |
| July 07, 2026 | 249.96M |
| July 06, 2026 | 264.70M |
| July 02, 2026 | 288.03M |
| July 01, 2026 | 273.91M |
| June 30, 2026 | 279.44M |
| June 29, 2026 | 291.10M |
| June 26, 2026 | 290.49M |
| June 25, 2026 | 268.38M |
| June 24, 2026 | 255.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.796B |
| Alnylam Pharmaceuticals, Inc. | 35.33B |
| Anika Therapeutics, Inc. | 281.18M |
| Savara, Inc. | 1.101B |
| Vericel Corp. | 2.073B |
Market Cap Related Metrics
| PS Ratio | 5.544 |
| PEG Ratio | -0.3887 |
| Price to Book Value | 46.78 |
| Price | 4.985 |
| Earnings Yield | -25.98% |
| PEGY Ratio | -0.3887 |